Multiple Cardiovascular Risk Factors Indicate Cardiovascular Disease in Stage 1 Hypertension

Area of Science:

• Cardiology
• Hypertension Management
• Cardiovascular Physiology

Background:

• The 2017 American College of Cardiology/American Heart Association guidelines redefined stage 1 hypertension, potentially increasing the number of adults requiring treatment.
• Adults over 40 with multiple cardiovascular risk factors often exhibit underlying hemodynamic abnormalities not detected by blood pressure (BP) alone.

Purpose of the Study:

• To evaluate the utility of impedance cardiography (ICG) in characterizing hemodynamic profiles of stage 1 hypertension patients with cardiovascular risk factors.
• To determine if ICG data can guide customized treatment strategies for improved BP control and cardiovascular disease (CV) prevention.

Main Methods:

• Utilized impedance cardiography (ICG) to assess hemodynamic parameters such as cardiac index and systemic vascular resistance.
• Analyzed ICG data in adults over 40 diagnosed with stage 1 hypertension and at least two cardiovascular risk factors.

Main Results:

• Impedance cardiography (ICG) identified prevalent ventricular, vascular, and hemodynamic abnormalities in the target patient group.
• Observed significant extremes in cardiac index and systemic vascular resistance in many stage 1 hypertension patients.
• Findings suggest that standard BP measurement alone may mask critical underlying hemodynamic issues.

Conclusions:

• Stage 1 hypertension patients over 40 with multiple CV risk factors may have early-stage CV disease.
• ICG provides crucial hemodynamic insights essential for effective hypertension management.
• Tailoring drug selection and titration based on ICG data can optimize BP control, minimize side effects, and prevent CV disease progression.